home / stock / huma / huma short
Short Information | Humacyte Inc. (NASDAQ:HUMA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 18,120,871 |
Total Actual Volume | 85,723,538 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 906,044 |
Average Short Percentage | 22.08% |
Is there a HUMA Short Squeeze or Breakout about to happen?
See the HUMA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-16-2024 | $8.84 | $8.79 | $8.99 | $8.1831 | 6,081,684 | 1,117,416 | 18.37% |
07-15-2024 | $7.5 | $8.4 | $8.71 | $7.27 | 10,119,997 | 2,228,867 | 22.02% |
07-12-2024 | $6.6 | $6.99 | $7 | $6.4125 | 3,471,051 | 786,574 | 22.66% |
07-11-2024 | $5.895 | $6.45 | $6.47 | $5.82 | 3,189,166 | 695,549 | 21.81% |
07-10-2024 | $5.97 | $5.72 | $6.2199 | $5.72 | 3,498,767 | 864,941 | 24.72% |
07-09-2024 | $5.75 | $5.855 | $6.0699 | $5.52 | 2,709,267 | 700,737 | 25.86% |
07-08-2024 | $5.37 | $5.67 | $5.89 | $5.345 | 3,714,781 | 1,160,963 | 31.25% |
07-05-2024 | $5.72 | $5.27 | $5.87 | $5.26 | 3,028,033 | 776,510 | 25.64% |
07-03-2024 | $5.1 | $5.67 | $5.85 | $5.09 | 2,432,053 | 569,362 | 23.41% |
07-02-2024 | $5.63 | $5.11 | $5.68 | $5.05 | 3,262,781 | 1,079,136 | 33.07% |
07-01-2024 | $5.36 | $5.37 | $6.3 | $5.05 | 9,067,415 | 3,025,998 | 33.37% |
06-28-2024 | $4.72 | $4.8 | $4.88 | $4.6 | 8,265,958 | 527,235 | 6.38% |
06-27-2024 | $4.95 | $4.7 | $5.11 | $4.65 | 2,495,924 | 578,663 | 23.18% |
06-26-2024 | $4.93 | $5 | $5.105 | $4.85 | 1,834,945 | 356,241 | 19.41% |
06-25-2024 | $5.1 | $4.93 | $5.22 | $4.92 | 3,169,946 | 1,184,529 | 37.37% |
06-24-2024 | $5.15 | $5.1 | $5.32 | $5.05 | 2,414,452 | 478,944 | 19.84% |
06-21-2024 | $5.22 | $5.17 | $5.36 | $5 | 6,835,415 | 525,036 | 7.68% |
06-20-2024 | $5.71 | $5.24 | $5.79 | $5.17 | 4,504,380 | 414,190 | 9.2% |
06-18-2024 | $6.19 | $5.935 | $6.3 | $5.9 | 2,121,384 | 343,898 | 16.21% |
06-17-2024 | $6.7 | $6.19 | $6.79 | $6.04 | 3,506,139 | 706,082 | 20.14% |
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, announced the addition of pharmaceutical industry veteran Dr. John P. Bamforth and di...
Pluristyx, a leading provider of tools, technologies, and services for the development of cellular therapies, is pleased to announce a license agreement with Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercia...
2024-07-01 10:28:20 ET Humacyte Inc (NASDAQ: HUMA) opened close to 25% up on Monday after the Food & Drug Administration granted its ATEV a special advanced-therapy designation. Shares of the biotech firm are still down some 30% versus their year-to-date high. Why does it ma...